cmlc2 is also known as mlc7 or myl7, and it displayed endogenous post-transcriptional down-regulation in murine models of Down’s syndrome, which implicates this gene in human congenital heart defects that are detected in a majority of Down’s syndrome patients [82,83]. Here, MYL7 is linked to Down syndrome.